A comparative study of liquid and solid inner contact roxatidine acetate ion-selective electrode membranes

Mohamed K. Abd El-Rahman Hala E. Zaazaa Samah S. Abbas Badr El-Zeany Zeinab A. EL-Sherif Dalia A. EL-Haddad

Citation:  Mohamed K. Abd El-Rahman, Hala E. Zaazaa, Samah S. Abbas, Badr El-Zeany, Zeinab A. EL-Sherif, Dalia A. EL-Haddad. A comparative study of liquid and solid inner contact roxatidine acetate ion-selective electrode membranes[J]. Chinese Chemical Letters, 2015, 26(6): 714-720. doi: 10.1016/j.cclet.2015.03.010 shu

A comparative study of liquid and solid inner contact roxatidine acetate ion-selective electrode membranes

    通讯作者: Hala E. Zaazaa,
摘要: A comparative study was conducted using two designs of a roxatidine acetate (ROX)-selective electrode; a conventional liquid inner contact called electrode A and a graphite-coated solid contact called electrode B. The fabrication of electrodes was based on roxatidine-tetraphenylborate (ROX-TPB) as an ion-association complex in a PVC matrix using different plasticizers. Electrode A has a linear dynamic range of 2.2×10-5 mol/L to 1.0×10-2 mol/L, with a Nernstian slope of 54.7 mV/decade and a detection limit of 1.4×10-6 mol/L. Electrode B shows linearity over the concentration range of 1.0×10-6 mol/L to 1.0×10-2 mol/L, with a Nernstian slope of 51.2 mV/decade and a limit of detection of 1.1×10-7 mol/L which is remarkably improved as a result of diminishing ion fluxes in this solid contact, ion-selective electrode. The proposed sensors display useful analytical characteristics for the determination of ROX in bulk powder and its pharmaceutical formulation. The present electrodes show clear discrimination of ROX from several inorganic, organic ions, sugars, some common drug excipients and the degradation product (3-[3-(1-piperidinyl methyl) phenoxy] propyl amine) of ROX. Furthermore, the proposed electrodes were utilized for the determination of ROX in human plasma, where electrode B covers drug Cmax which indicated its applicability to pharmacokinetic, bioavailability and bioequivalent studies. The results obtained by the proposed electrodes were statistically analyzed and compared with those obtained by a reported HPLC method. No significant difference for either accuracy or precision was observed.

English

  • 
    1. [1] N.J.O. Maryadele, An Encyclopedia of Chemicals, Drug and Biologicals, 14th ed., The Merck Index, Division of Merck and Co. Inc., Merck Research Laboratories, White House Station, NJ, USA, 2006p. 1429.[1] N.J.O. Maryadele, An Encyclopedia of Chemicals, Drug and Biologicals, 14th ed., The Merck Index, Division of Merck and Co. Inc., Merck Research Laboratories, White House Station, NJ, USA, 2006p. 1429.

    2. [2] S. Honma, R. Akutsu, S. Iwamura, Y. Kawabe, K. Tsukamoto, Metabolic fate of 2-acetoxy-N-[3-[m-(1-piperidinylmethyl)phenoxy]propyl] acetamide hydrochloride (TZU-0460), a new H2-receptor antagonist (8) the metabolism in man, Pharmacometrics 30 (1985) 555-563.[2] S. Honma, R. Akutsu, S. Iwamura, Y. Kawabe, K. Tsukamoto, Metabolic fate of 2-acetoxy-N-[3-[m-(1-piperidinylmethyl)phenoxy]propyl] acetamide hydrochloride (TZU-0460), a new H2-receptor antagonist (8) the metabolism in man, Pharmacometrics 30 (1985) 555-563.

    3. [3] W. Rösch, A comparison of roxatidine acetate 150 mg once daily and 75 mg twice daily in gastric ulcer healing, Drugs 35 (1988) 127-133.[3] W. Rösch, A comparison of roxatidine acetate 150 mg once daily and 75 mg twice daily in gastric ulcer healing, Drugs 35 (1988) 127-133.

    4. [4] C.W. Kuo, W.J. Liaw, P.W. Huang, L.H. Pao, A rapid and sensitive HPLC method for determination of roxatidine in human plasma, J. Food Drug Anal. 16 (2008) 1-5.[4] C.W. Kuo, W.J. Liaw, P.W. Huang, L.H. Pao, A rapid and sensitive HPLC method for determination of roxatidine in human plasma, J. Food Drug Anal. 16 (2008) 1-5.

    5. [5] B.S. Shin, J.W. Choi, J.P. Balthasar, D.K. Hong, J.J. Kim, S.D. Yoo, Determination of roxatidine in human plasma by liquid chromatography/electrospray mass spectrometry and application to a clinical pharmacokinetic study, Rapid Commun. Mass Spectrom. 21 (2007) 329-335.[5] B.S. Shin, J.W. Choi, J.P. Balthasar, D.K. Hong, J.J. Kim, S.D. Yoo, Determination of roxatidine in human plasma by liquid chromatography/electrospray mass spectrometry and application to a clinical pharmacokinetic study, Rapid Commun. Mass Spectrom. 21 (2007) 329-335.

    6. [6] J.H. Ryu, S.J. Choi, H.W. Lee, S.K. Choi, K.T. Lee, Quantification of roxadine in human plasma by liquid chromatography electrospray ionization tandem mass spectrometry: application to a bioequivalence study, J. Chromatogr. B 876 (2008) 143-147.[6] J.H. Ryu, S.J. Choi, H.W. Lee, S.K. Choi, K.T. Lee, Quantification of roxadine in human plasma by liquid chromatography electrospray ionization tandem mass spectrometry: application to a bioequivalence study, J. Chromatogr. B 876 (2008) 143-147.

    7. [7] S. Iwamura, K. Shibata, Y. Kawabe, K. Tsukamoto, S. Honma, The metabolism of roxatidine acetate hydrochloride in rat and dog liver homogenates, J. Pharmacobiodyn. 10 (1987) 229-235.[7] S. Iwamura, K. Shibata, Y. Kawabe, K. Tsukamoto, S. Honma, The metabolism of roxatidine acetate hydrochloride in rat and dog liver homogenates, J. Pharmacobiodyn. 10 (1987) 229-235.

    8. [8] J.L. Burrows, K.W. Jolley, D.J. Sullivan, Determination of roxatidine in human plasma, urine and milk by capillary gas chromatography using nitrogen-selective detection, J. Chromatogr. B 432 (1988) 199-208.[8] J.L. Burrows, K.W. Jolley, D.J. Sullivan, Determination of roxatidine in human plasma, urine and milk by capillary gas chromatography using nitrogen-selective detection, J. Chromatogr. B 432 (1988) 199-208.

    9. [9] N. Rahman, M. Kashif, Optimized and validated spectrophotometric methods for the determination of roxatidine acetate hydrochloride in drug formulations using 2,3-dichloro-5,6-dicyano-1,4-benzoquinone and p-chloranilic acid, J. Anal. Chem. 60 (2005) 636-643.[9] N. Rahman, M. Kashif, Optimized and validated spectrophotometric methods for the determination of roxatidine acetate hydrochloride in drug formulations using 2,3-dichloro-5,6-dicyano-1,4-benzoquinone and p-chloranilic acid, J. Anal. Chem. 60 (2005) 636-643.

    10. [10] J.J.B. Nevado, G.C. Penalvo, R.M.R. Dorado, Evaluation of non-aqueous capillary zone electrophoresis for the determination of histamine H2 receptor antagonists in pharmaceuticals, Anal. Sci. 27 (2011) 427-432.[10] J.J.B. Nevado, G.C. Penalvo, R.M.R. Dorado, Evaluation of non-aqueous capillary zone electrophoresis for the determination of histamine H2 receptor antagonists in pharmaceuticals, Anal. Sci. 27 (2011) 427-432.

    11. [11] S.S. Abbas, H.E. Zaazaa, Z.A. EL-Sherif, D.A. Elhadad, B. EL-Zeany, Optimization of stability-indicating chromatographic methods for the determination of roxatidine acetate in the presence of its degradation products, Int. J. Pharm. Pharm. Sci. 6 (2014) 149-157.[11] S.S. Abbas, H.E. Zaazaa, Z.A. EL-Sherif, D.A. Elhadad, B. EL-Zeany, Optimization of stability-indicating chromatographic methods for the determination of roxatidine acetate in the presence of its degradation products, Int. J. Pharm. Pharm. Sci. 6 (2014) 149-157.

    12. [12] A. Radu, A.J. Meir, E. Bakker, Dynamic diffusion model for tracing the real-time potential response of polymeric membrane ion-selective electrodes, Anal. Chem. 76 (2004) 6402-6409.[12] A. Radu, A.J. Meir, E. Bakker, Dynamic diffusion model for tracing the real-time potential response of polymeric membrane ion-selective electrodes, Anal. Chem. 76 (2004) 6402-6409.

    13. [13] S. Mathison, E. Bakker, Effect of transmembrane electrolyte diffusion on the detection limit of carrier-based potentiometric ion sensors, Anal. Chem. 70 (1998) 303-309.[13] S. Mathison, E. Bakker, Effect of transmembrane electrolyte diffusion on the detection limit of carrier-based potentiometric ion sensors, Anal. Chem. 70 (1998) 303-309.

    14. [14] E. Bakker, E. Pretsch, Potentiometric sensors for trace-level analysis, TrAC Trends Anal. Chem. 24 (2005) 199-207.[14] E. Bakker, E. Pretsch, Potentiometric sensors for trace-level analysis, TrAC Trends Anal. Chem. 24 (2005) 199-207.

    15. [15] H. Ibrahim, Y.M. Issa, H.M. Abu-Shawish, Improving the detection limits of antispasmodic drugs electrodes by using modified membrane sensors with inner solid contact, J. Pharm. Biomed. Anal. 44 (2007) 8-15.[15] H. Ibrahim, Y.M. Issa, H.M. Abu-Shawish, Improving the detection limits of antispasmodic drugs electrodes by using modified membrane sensors with inner solid contact, J. Pharm. Biomed. Anal. 44 (2007) 8-15.

    16. [16] T. Masadome, J. Yang, T. Imato, Effect of plasticizer on the performance of the surfactant-selective electrode based on a poly(vinyl chloride) membrane with no added ion-exchanger, Microchim. Acta 144 (2004) 217-220.[16] T. Masadome, J. Yang, T. Imato, Effect of plasticizer on the performance of the surfactant-selective electrode based on a poly(vinyl chloride) membrane with no added ion-exchanger, Microchim. Acta 144 (2004) 217-220.

    17. [17] I. Švancara, K. Vytřas, J. Barek, J. Zima, Carbon paste electrodes in modern electroanalysis, Crit. Rev. Anal. Chem. 31 (2001) 311-345.[17] I. Švancara, K. Vytřas, J. Barek, J. Zima, Carbon paste electrodes in modern electroanalysis, Crit. Rev. Anal. Chem. 31 (2001) 311-345.

    18. [18] H.M. Abu-Shawish, Potentiometric response of modified carbon paste electrode based on mixed ion exchangers, Electroanalysis 20 (2008) 491-497.[18] H.M. Abu-Shawish, Potentiometric response of modified carbon paste electrode based on mixed ion exchangers, Electroanalysis 20 (2008) 491-497.

    19. [19] V.S. Bhat, V.S. Ijeri, K.A. Srivastava, Coated wire lead(II) selective potentiometric sensor based on 4-tert-butylcalix[6]arene, Sens. Actuators B 99 (2004) 98-105.[19] V.S. Bhat, V.S. Ijeri, K.A. Srivastava, Coated wire lead(II) selective potentiometric sensor based on 4-tert-butylcalix[6]arene, Sens. Actuators B 99 (2004) 98-105.

    20. [20] H.M. Abu Shawish, A.M. Khedr, K.I. Abed-Almonem, M. Gaber, A comparative study of solid and liquid inner contact benzalkonium chloride ion-selective electrode membranes, Talanta 101 (2012) 211-219.[20] H.M. Abu Shawish, A.M. Khedr, K.I. Abed-Almonem, M. Gaber, A comparative study of solid and liquid inner contact benzalkonium chloride ion-selective electrode membranes, Talanta 101 (2012) 211-219.

    21. [21] M.A.A. Pérez, L.P. Marín, J.C. Quintana, M.Y. Pedram, Influence of different plasticizers on the response of chemical sensors based on polymeric membranes for nitrate ion determination, Sens. Actuators B 89 (2003) 262-268.[21] M.A.A. Pérez, L.P. Marín, J.C. Quintana, M.Y. Pedram, Influence of different plasticizers on the response of chemical sensors based on polymeric membranes for nitrate ion determination, Sens. Actuators B 89 (2003) 262-268.

    22. [22] W. Wroblewski, K. Wojciechowski, A. Dybko, et al., Uranyl salophenes as ionophores for phosphate-selective electrodes, Sens. Actuators B: Chem. 68 (2000) 313-318.[22] W. Wroblewski, K. Wojciechowski, A. Dybko, et al., Uranyl salophenes as ionophores for phosphate-selective electrodes, Sens. Actuators B: Chem. 68 (2000) 313-318.

    23. [23] R. IUPAC, Analytical chemistry division, commission on analytical nomenclature, Pure Appl. Chem. 72 (2000) 1851-2082.[23] R. IUPAC, Analytical chemistry division, commission on analytical nomenclature, Pure Appl. Chem. 72 (2000) 1851-2082.

    24. [24] N.T. Abdel Ghani, M.S. Rizk, R.M. El-Nashar, Salbutamol plastic membrane electrodes based on individual and mixed ion-exchangers of salbutamolium phosphotungstate and phosphomolybdate, Analyst 125 (2000) 1129-1133.[24] N.T. Abdel Ghani, M.S. Rizk, R.M. El-Nashar, Salbutamol plastic membrane electrodes based on individual and mixed ion-exchangers of salbutamolium phosphotungstate and phosphomolybdate, Analyst 125 (2000) 1129-1133.

    25. [25] H.B. Lassman, I. Ho, S.K. Puri, R. Sabo, M.R. Scheffler, The pharmacodynamics and pharmacokinetics of multiple doses of the new H2-receptor antagonist, roxatidine acetate, in healthy men, Drugs 35 (1988) 53-64.[25] H.B. Lassman, I. Ho, S.K. Puri, R. Sabo, M.R. Scheffler, The pharmacodynamics and pharmacokinetics of multiple doses of the new H2-receptor antagonist, roxatidine acetate, in healthy men, Drugs 35 (1988) 53-64.

  • 加载中
计量
  • PDF下载量:  0
  • 文章访问数:  1214
  • HTML全文浏览量:  45
文章相关
  • 发布日期:  2015-03-19
  • 收稿日期:  2014-09-17
  • 网络出版日期:  2014-12-15
通讯作者: 陈斌, bchen63@163.com
  • 1. 

    沈阳化工大学材料科学与工程学院 沈阳 110142

  1. 本站搜索
  2. 百度学术搜索
  3. 万方数据库搜索
  4. CNKI搜索

/

返回文章